Echeverrí JL, Pérez IM, Torra BOL

Language: Spanish
References: 30
Page: 329-337
PDF size: 375.45 Kb.

ABSTRACT

Introduction: the reasons for admission to the intensive care unit (ICU) have been studied in patients with the human immunodeficiency virus (HIV). Prevalence and mortality remain high in Colombia, with limited access to antiretroviral therapy, which has translated into high costs and poor survival outcomes. Objective: to characterize social demographically and clinically critically ill patients diagnosed with HIV admitted to the ICU in the city of Medellín. Material and methods: an observational, descriptive, cross-sectional study was carried out by reviewing the medical records of patients treated in an ICU during the years 2008-2011. Results: 154 patients were included. The most frequent cause of ICU admission was acute respiratory failure (46.7%), with a reported ICU mortality of 41.6%. The three most frequent infections found that generated acute respiratory failure as a cause of admission to the ICU were Pneumocystis jirovecii pneumonia 21.4%, pulmonary tuberculosis 18.2%, and nosocomial pneumonia acquired during the hospital stay (15.6%). The risk factors associated with mortality were: the use of mechanical ventilation, the requirement for CRRT, the presence of malnutrition, and the appearance of complications in the ICU. Conclusions: the characteristics of our sample are like those reported in other series; they differ in the type of opportunistic infections and the mortality attributable to HIV/AIDS infection. The main cause of admission to intensive care was acute respiratory failure, followed by neurological compromise and sepsis. Pneumocystis jirovecii is the most common opportunistic infection.

REFERENCES

1. Croda J, Croda MG, Neves A, De Sousa dos Santos S. Benefit of antiretroviral therapy on survival of human immunodeficiency virus-infected patients admitted to an intensive care unit. Crit Care Med. 2009;37(5):1605-1611.

2. Morris A, Creasman J, Turner J, Luce JM, Wachter RM, Huang L. Intensive care of human immunodeficiency virus-infected patients during the era of highly active antiretroviral therapy. Am J Respir Crit Care Med. 2002;166(3):262-267.

3. Rosen MJ. Intensive care of patients with human immunodeficiency virus infection: time to take another look. J Intensive Care Med. 2005;20(6):312-315.

4. Barbier F, Roux A, Canet E, et al. Temporal trends in critical events complicating HIV infection: 1999-2010 multicenter cohort study in France. Intensive Care Med. 2014;40(12):1906-1915.

5. Trindade BP, Karen Rodrigues de CV, Ferreira JMA, Pereira FO. Hospitalização de adultos com Aids em unidade de terapia intensiva: estudo analítico. Online Braz J Nurs. 2021.

6. Kidney disease: improving global outcome (KDIGO) acute kidney injury work group Section 2: AKI definition. Kidney Int. (2012;Suppl 2:19-36.

7. Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165-228.

8. ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS. acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307:2526-2533.

9. Kaplan JE, Benson C, Holmes KK, et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recommendations Rep. 2009;58(RR-4):1-207; quiz CE1-4. Available in: https://pubmed.ncbi.nlm.nih.gov/19357635/

10. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-829.

11. Center for Disease Control and Prevention. Revised guidelines for HIV counseling, testing, and referral. MMWR Recommend Rep. 2001;50(RR-19):1-57.

12. Ministerio de Salud y Protección Social. Informe GARPR 2014-Seguimiento de la declaración de compromiso sobre el VIH/SIDA. Bogotá: Ministerio de Salud y Protección Social; 2014.

13. Penagos Gaviria S, Zapata N, et al. HIV/AIDS infection in critical care: epidemiological profile and risk factors for mortality in a Colombian cohort. The J Infec Dev Ctries. 2023;17(01):102-110.

14. Turvey SL, Bagshaw SM, Eurich DT, Sligl WI. Epidemiology and outcomes in critically ill patients with human immunodeficiency virus infection in the era of combination antiretroviral therapy. Can J Infect Dis Med Microbiol. 2017;2017:1-9.

15. Barbier F, Coquet I, Legriel S, et al. Etiologies and outcome of acute respiratory failure in HIV-infected patients. Intensive Care Med. 2009;35(10):1678-1686.

16. Morquin D, Le Moing V, Mura T, et al. Short- and long-term outcomes of HIV-infected patients admitted to the intensive care unit: impact of antiretroviral therapy and immunovirological status. Ann Intensive Care. 2012;2(1):25.

17. Masur H. Caring for AIDS patients in the ICU. Chest. 2009;135(1):1-2.

18. Powell K, J. Lucian Davis, Morris A, Chi A, Bensley MR, Huang L. Survival for patients with HIV admitted to the ICU continues to improve in the current era of combination antiretroviral therapy. Chest. 2009;135(1):11-17.

19. Chiang HH, Hung CC, Lee CM, et al. Admissions to intensive care units of HIV-infected patients in the era of highly active antiretroviral therapy: etiology and prognostic factors. Crit Care. 2011;15(4):R202.

20. Montúfar AF, Quiroga A, Builes C, et al. Epidemiología de la infección por el virus de inmunodeficiencia humana en pacientes hospitalizados en una institución de alta complejidad y enseñanza universitaria en Medellín, Colombia. Infectio. 2016;20(1):9-16.

21. Montúfar-Andrade FE, Villa-Franco JP, Montúfar-Pantoja MC, et al. Compromiso pulmonar en pacientes hospitalizados con infección por el virus de inmunodeficiencia humana en el Hospital Pablo Tobón Uribe (Medellín, Colombia). Infectio. 2016;20(4):211-217.

22. OMS, Organización Mundial de la Salud. Tuberculosis Profile, Colombia, 2017.

23. Beltrán M, Pérez F, Sánchez L, et al. Prevalencia y factores asociados a tuberculosis y micobacteriosis en pacientes VIH positivos en Bogotá. Biomédica. 2018;38(1):120-127.

24. Balkema CA, Irusen EM, Taljaard JJ, Zeier MD, Koegelenberg CF. A prospective study on the outcome of human immunodeficiency virus-infected patients requiring mechanical ventilation in a high-burden setting. QJM. 2015;109(1):35-40.

25. Atrash A, De Vasconcellos K. Low albumin levels are associated with mortality in the critically ill: a retrospective observational study in a multidisciplinary intensive care unit. Southern Afr J Crit Care. 2020;36(2):74. Available in: http://www.scielo.org.za/pdf/sajcc/v36n2/02.pdf

26. Powell K, Huang L. The ART of caring for patients with HIV infection in the ICU. Intensive Care Medicine. 2009;35(10):1659-1661.

27. Álvarez BMF, Restrepo CCA, Hidrón BA, et al. Hospitalization causes and outcomes in HIV patients in the late antiretroviral era in Colombia. AIDS Res Ther. 2017;14(1):60.

28. Sepúlveda CG, Zúñiga ÁM, Amaya GA, et al. Características sociodemográficas y determinantes de adhesión terapéutica antirretroviral en pacientes con VIH/SIDA en dos instituciones de Bogotá. Rev Colomb Enferm. 2009;4(4). Disponible en: http://www. uelbosque.edu.co/sites/default/files/publicaciones/revistas/revista_colombiana_en fermeria/volumen4/caracteristicas_sociodemograficas_determinantes_adhesion_te rapeutica_antirretroviral_pacientes_vih_sida.pdf

29. Saúl P, Cunto E, Villar O, et al. Utility of a mortality predictive score in patients with HIV/AIDS in intensive care. Actual en SIDA E Infectol. 2013;21:107-113.

30. Amancio FF, Lambertucci JR, Cota GF, Antunes CM. Predictors of the short- and long-term survival of HIV-infected patients admitted to a Brazilian intensive care unit. Int J STD AIDS. 2012;23(10):692-697. Available from: https://pubmed.ncbi.nlm.nih.gov/23104742/